[Tranexamic acid and arthroplasty: between off-label use and evidence-based medicine]
- PMID: 34115141
- PMCID: PMC8193179
- DOI: 10.1007/s00101-021-00989-6
[Tranexamic acid and arthroplasty: between off-label use and evidence-based medicine]
Comment in
-
[Tranexamic acid: the importance of correct use and individualized risk-benefit analysis].Anaesthesist. 2021 Jul;70(7):616-617. doi: 10.1007/s00101-021-00990-z. Epub 2021 Jun 11. Anaesthesist. 2021. PMID: 34115142 German. No abstract available.
Comment on
-
[Tranexamic acid for bleeding prophylaxis in orthopedic surgery and trauma-standard or customized therapy?].Anaesthesist. 2021 Jun;70(6):515-521. doi: 10.1007/s00101-021-00928-5. Epub 2021 Feb 23. Anaesthesist. 2021. PMID: 33620508 Free PMC article. Review. German.
References
-
- Arbeitsgemeinschaft Der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (2015) S3-Leitlinie 003-001: Prophylaxe der venösen Thromboembolie (VTE). http://www.awmf.org/leitlinien/detail/ll/003-001.html. Zugegriffen: 20. Aug. 2020
-
- Fillingham YA, Ramkumar DB, Jevsevar DS, et al. Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. J Arthroplasty. 2018;33:3065–3069. doi: 10.1016/j.arth.2018.08.002. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
